Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cassava Sciences Announces Expansion of Open-Label Extension Trials
-
Vislink to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024, at 8:30 a.m. ET
-
Acronis H1 2024 Cyberthreats Report Highlights a 293% Surge in Email Attacks
-
Yamo Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of L1-79 for the Treatment of the Core Symptoms of Autism
-
NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer’s Association International Conference
-
Lofty Introduces Property Management System, LoftyWorks
-
Sonoro Gold Corrects Disclosures Related to Its Cerro Caliche Project in Mexico
-
PTX Metals Announces Additional Wide Zones of Near Surface Copper Nickel PGE Mineralization at W2 Project
-
Better Health Outcomes for Seniors, Improved Access to Care and Reduced Environmental Footprint Are Top Achievements Noted in Alignment Healthcare’s 3rd Annual ESG Report
-
Locus Technologies Successfully Completes SOC 1 and SOC 2 Audits
-
Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
-
Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease
-
Tive Celebrates 60% Year-over-Year Revenue Growth
-
Comscore Introduces Comprehensive YouTube Audience Measurement Across All Digital Devices
-
ITW Reports Second Quarter 2024 Results
-
CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference
-
IPG Photonics Announces Second Quarter 2024 Financial Results
-
Award-Winning Material Inventor Joins as Advisor for AI Innovator of Climate Technologies
-
Arq to Host Second Quarter 2024 Conference Call on August 13, 2024
-
X4 Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 8, 2024
-
LifeMD to Report Second Quarter 2024 Financial Results on August 7
-
VERSES Publishes Pioneering Research Demonstrating More Versatile, Efficient, Physics Foundation for Next-Gen AI
-
Polar Power Appoints Michael Field as Independent Director and Compensation Committee Chair
-
Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
-
Ocean Power Technologies Expands in Latin America with Reseller Agreement in Costa Rica
-
Gaxos Health Announces Commercial Launch
-
PenLink Appoints Distinguished Leaders to Advisory Board
-
Dragonfly Energy Enters into $30M Licensing Agreement for Battle Born Batteries Brand with Stryten Energy, a Leading North American Battery Manufacturer
-
CTS Announces Second Quarter 2024 Results
-
Duos Technologies Group Sets Second Quarter 2024 Earnings Call for Tuesday, August 13, 2024 at 4:30 PM ET
-
Asset Entities Completes $3 Million Series A Convertible Preferred Stock Transaction Receiving Additional Gross Proceeds of $1.5 Million
-
Armlogi Expands Warehouse Capacity to Support Growing Trucking Operations and Partnership with Massimo
-
red violet to Announce Second Quarter 2024 Financial Results on August 7, 2024
-
Dave Cantin Group and Kaiser Associates’ Market Outlook Report-Midyear Update Says EVs Are Here to Stay, Your Local Dealers Might Not Be, and Consumers Will Force Any President to Let More Foreign C
-
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
-
Comscore Introduces Comprehensive YouTube Audience Measurement Across All Digital Devices
-
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
-
Voting on CareCloud’s Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal
-
IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001
-
Ovid Therapeutics to Present at Upcoming August Investor Conferences
-
Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024
-
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
-
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
-
Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease
-
Martinrea International Inc. to Announce Second Quarter Results on August 6, 2024
-
Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024
-
Quark Global Survey Shows Organizations Recognize the Potential of AI in Strengthening Enterprise Content Strategies
-
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
-
HireVue Achieves Certification Under the US Department of Commerce’s Data Privacy Framework
-
aTyr Pharma Announces Research Study with Stanford Medicine

